Most preterm infants less than 35 weeks gestational age (GA) have elevated total
serum/plasma bilirubin (TB) levels, which often present as jaundice, the yellowish …

Hyperbilirubinemia is the most common clinical condition requiring evaluation and treatment
in the newborn [1] and the most common cause for hospital readmission during the first …

Hyperbilirubinemia is the most common condition requiring evaluation and treatment of
newborns, but for the vast majority of neonates, it is a benign, transitional phenomenon of no …

More than 60% of newborns appear clinically jaun-diced in the first few weeks of life, 1 most
often due to physiologic jaundice. Mild hyperbilirubinemia peaks at Days 3 to 5 and returns …

Hyperbilirubinemia and kernicterus are re-emerging as prominent clinical concerns and
have been hypothesized to be secondary to increased breast-feeding rates, early hospital …

Neonatal jaundice is the medical condition most commonly encountered by the pediatrician
and neonatologist. Approximately 60% of healthy term neonates have clinical jaundice …

Hyperbilirubinemia is the most common condition requiring evaluation and treatment in
neonates, but for most newborns, it is a benign postnatal transitional phenomenon of no …

The primary goal of the evaluation and management of unconjugated hyperbilirubinemia in
premature infants is to prevent acute and chronic bilirubin-induced neurotoxicity, a spectrum …

Abstract In 1992, Kobe University proposed treatment criteria for hyperbilirubinemia in
newborns using total serum bilirubin and serum unbound bilirubin reference values. In the …

Background: Severe neonatal hyperbilirubinemia, when unmonitored or untreated, can
progress to acute bilirubin encephalopathy (ABE). Initiatives to prevent and eliminate post …